[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"alcoholic-liver-cirrhosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:alcoholic-liver-cirrhosis":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100446472","long-term-follow-up-of-patients-with-alcoholic-liver-cirrhosis-who-had-administered-cellgram-lc-in-pmc-p-07-study-100446472",false,"NCT05093881","Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC","Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study","Inclusion Criteria:\n\n1. Participants who received Cellgram-LC in the PMC-P-07 clinical trial.\n2. Participants who voluntarily provide written informed consent to participate in this study.\n\nExclusion Criteria:\n\n\\- None.","ALL","19 Years","70 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the long-term safety of Cellgram-LC in patients with alcoholic liver cirrhosis who previously received Cellgram-LC in the PMC-P-07 study.\n\nThe main question it aims to answer is:\n\n\\- Do adverse event of special interest (AESI) or liver transplantation occur during the 5 years after Cellgram-LC administration?\n\nParticipants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily consent to participate in this long-term follow-up study will be followed for 5 years after Cellgram-LC administration through telephone visits to collect information on AESI and liver transplantation.",[25],"Alcoholic Liver Cirrhosis",[27,28,29,30,31,32],"Cellgram-LC","Long-Term Follow-up","Adverse Events of Special Interest","Liver Transplantation","Autologous Bone Marrow-Derived Mesenchymal Stem Cell","Mesenchymal Stem Cell","RECRUITING","2026-09-16",{"date":36,"type":37},"2026-09-21","ACTUAL",{"date":39,"type":37},"2021-09-09",{"date":41,"type":21},"2031-12-31",{"name":43,"class":44},"Pharmicell Co., Ltd.","INDUSTRY",14]